However, research indicates that 36% of people with obesity would be more likely to consider treatment if a daily pill were available instead of weekly injections
Most patients notice changes within the first few weeks, with significant results typically visible within 3-6 months
Combining genetic context with liver-function biomarkers and medication history enables more personalized decisions about supplementation safety, timing, and expected outcomes
Patients should expect to talk about weight history, appetite cues, cravings, meal timing, exercise limitations, prior medication response, family history, sleep, stress, and medical risks
Additionally, individuals who are currently taking medications that interact with Semaglutide GLP-1, such as insulin or other medications that lower blood sugar should consult their healthcare provider before using Semaglutide GLP-1
Order yours today and see what makes Polar Peptides the #1 choice in Canada